Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI

被引:8
|
作者
Zhang, Yan-Nan [1 ]
Lu, Zhen-Guo [1 ]
Wang, Shuai-Dong [2 ]
Lu, Xin [1 ]
Zhu, Lei-Lei [1 ]
Yang, Xu [1 ]
Fu, Li-Ping [1 ]
Zhao, Jun [3 ]
Wang, Hai-Feng [2 ]
Xiang, Zuo-Lin [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Radiat Oncol, Shanghai 200120, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Urol, Shanghai 200120, Peoples R China
[3] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Nucl Med, Shanghai 200120, Peoples R China
基金
中国国家自然科学基金;
关键词
Prostate cancer; Gross tumor volume; Radiotherapy; PSMA PET; MRI; HYBRID PET/MRI; PET/CT; VALIDATION; PSMA; MRI; RECURRENCE; GUIDELINES; LESIONS;
D O I
10.1186/s40644-022-00475-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to assess the clinical value of F-18-PSMA-1007 and Ga-68-PSMA-11 PET/MRI in the gross tumor volume (GTV) delineation of radiotherapy for prostate cancer (PCa). Methods Sixty-nine patients were retrospectively enrolled (57 in the F-18 subgroup and 12 in the Ga-68 subgroup). Three physicians delineated the GTV and tumor length by the visual method and threshold method with thresholds of 30%, 40%, 50%, and 60% SUVmax. The volume correlation and differences in GTVs were assessed. The dice similarity coefficient (DSC) was applied to estimate the spatial overlap between GTVs. For 51 patients undergoing radical prostatectomy, the tumor length (Lpath) of the maximum area was measured, and compared with the longest tumor length obtained based on the images (L-MRI, L-PET/MRI, L-PET, L-PET30%, L-PET40%, L-PET50%, L-PET60%) to determine the best delineation method. Results In the F-18 subgroup, (1) GTV-PET/MRI (p < 0.001) was significantly different from the reference GTV-MRI. DSC between them was > 0.7. (2) GTV-MRI (R-2 = 0.462, p < 0.05) was the influencing factor of DSC. In the Ga-68 subgroup, (1) GTV-PET/MRI (p < 0.05) was significantly different from the reference GTV-MRI. DSC between them was > 0.7. (2) There was a significant correlation between GTV-MRI (r = 0.580, p < 0.05) and DSC. The longest tumor length measured by PET/MRI was in good agreement with that measured by histopathological analysis in both subgroups. Conclusion It is feasible to visually delineate GTV on PSMA PET/MRI in PCa radiotherapy, and we emphasize the utility of PET/MRI fusion images in GTV delineation. In addition, the overlap degree was the highest between GTV-MRI and GTV-PET/MRI, and it increased with increasing volume.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in recurrent Prostate Cancer
    Ceci, F.
    Polverari, G.
    Gartmann, J.
    Fendler, W.
    Eiber, M.
    Herrmann, K.
    Czernin, J.
    Calais, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S150 - S150
  • [42] Ga68PSMA PET/MRI a revolution to detect primary prostate cancer
    Schachoff, Sylvia
    Maurer, Tobias
    Nekolla, Stephan
    Schwaiger, Markus
    Weber, Wolfgang
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [43] Integrated 68Ga-PSMA-11 PET/MRI enhances discriminatory power of multi-parametric prostate MRI
    Al-Bayati, M.
    Grueneisen, J.
    Luetje, S.
    Sawicki, L.
    Suntharalingam, S.
    Tschirdewahn, S.
    Forsting, M.
    Herrmann, K.
    Umutlu, L.
    Wetter, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S164 - S164
  • [44] The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET
    Holzschuh, Julius C.
    Mix, Michael
    Freitag, Martin T.
    Hoelscher, Tobias
    Braune, Anja
    Kotzerke, Jorg
    Vrachimis, Alexis
    Doolan, Paul
    Ilhan, Harun
    Marinescu, Ioana M.
    Spohn, Simon K. B.
    Fechter, Tobias
    Kuhn, Dejan
    Gratzke, Christian
    Grosu, Radu
    Grosu, Anca-Ligia
    Zamboglou, C.
    RADIATION ONCOLOGY, 2024, 19 (01)
  • [45] Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer
    Bidakhvidi, Niloefar Ahmadi
    Gevaert, Thomas
    De Schepper, Maxim
    Baldewijns, Marcella
    Havinga, Enrique
    Deckers, Wies
    Laenen, Annouschka
    Devos, Gaetan
    Giesen, Alexander
    Joniau, Steven
    Koole, Michel
    Everaerts, Wouter
    Deroose, Christophe M.
    Goffin, Karolien
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, : 766 - 778
  • [46] Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies
    Huasong Huo
    Shurui Shen
    Ding He
    Bin Liu
    Fuwei Yang
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 16 - 24
  • [47] Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies
    Huo, Huasong
    Shen, Shurui
    He, Ding
    Liu, Bin
    Yang, Fuwei
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 16 - 24
  • [48] Comparative analysis of the accuracy in the delineation of intraprostatic carcinoma lesions by using of hybrid image 68Ga-PSMA-PET/MRI, as well as 18F-PSMA-PET and 68Ga-PSMA-PET complemented with multiparametric MRI
    Scobioala, S.
    Kittel, C.
    Wolters, H.
    Oertel, M.
    Kroeger, K.
    Schaefers, M.
    Rahbar, K.
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S91 - S91
  • [49] Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy
    Kranzbuhler, Benedikt
    Nagel, Hannes
    Becker, Anton S.
    Mueller, Julian
    Huellner, Martin
    Stolzmann, Paul
    Muehlematter, Urs
    Guckenberger, Matthias
    Kaufmann, Philipp A.
    Eberli, Daniel
    Burger, Irene A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (01) : 20 - 30
  • [50] Clinical value of 18F-PSMA-1007 PET/MRI in primary staging of patients with intermediate- to high-risk prostate cancer
    Ali, Ismail
    Rezk, Mahmoud
    Hamouda, Dalia
    Talaat, Omnia
    Omar, Yehia
    Abdel Tawab, Mohamed
    Nasr, Ibrahim
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1155): : 622 - 631